Myotonic dystrophy type 1 (DM1) is caused by the expansion of CTG repeats in the 3 ′ untranslated region of the DMPK gene. Several missplicing events and transcriptional alterations have been described in DM1 patients. A large number of these defects have been reproduced in animal models expressing CTG repeats alone. Recent studies have also reported miRNA dysregulation in DM1 patients. In this work, a Drosophila model was used to investigate miRNA transcriptome alterations in the muscle, specifically triggered by CTG expansions. Twenty miRNAs were differentially expressed in CTG-expressing flies. Of these, 19 were down-regulated, whereas 1 was up-regulated. This trend was confirmed for those miRNAs conserved between Drosophila and humans (miR-1, miR-7 and miR-10) in muscle biopsies from DM1 patients. Consistently, at least seven target transcripts of these miRNAs were up-regulated in DM1 skeletal muscles. The mechanisms involved in dysregulation of miR-7 included a reduction of its primary precursor both in CTG-expressing flies and in DM1 patients. Additionally, a regulatory role for Muscleblind (Mbl) was also suggested for miR-1 and miR-7, as these miRNAs were down-regulated in flies where Mbl had been silenced. Finally, the physiological relevance of miRNA dysregulation was demonstrated for miR-10, since overexpression of this miRNA in Drosophila extended the lifespan of CTG-expressing flies. Taken together, our results contribute to our understanding of the origin and the role of miRNA alterations in DM1.
INTRODUCTION
Myotonic dystrophy type 1 (DM1) is a chronic, slowly progressing multisystemic disease, with symptoms that include loss of muscle strength, myotonia and excessive fatigue (OMIM #160900). DM1 is caused by a dynamic expansion of CTG repeats in the 3 ′ untranslated region of the dystrophia † Present address: Valentia BioPharma, Paterna 46980, Spain. ‡ Present address: Department of Experimental Biology, University of Jaen, Jaen 23071, Spain. *
To whom correspondence should be addressed at: Departamento de Genetica, C/ Doctor Moliner, 50, E-46100 Burjasot, Spain. Tel: +34 963543028; Fax: +34 963543029; Email: ruben.artero@uv.es myotonica-protein kinase (DMPK) gene (for a recent review, see 1) . Characteristic molecular features of the disease have been associated with a toxic RNA gain of function of the CUG expansions. Expanded CUG repeats have been demonstrated to be toxic per se in several cell types and animal models (2 -4) , disrupting transcription and alternative splicing of at least 175 genes and 156 defined pre-mRNAs in mice, respectively (5) . Expanded CUG repeats sequester nuclear proteins and accumulate into distinctive foci within muscle and neuronal nuclei (6) (7) (8) . The alternative splicing factor Muscleblind-like 1 (MBNL1) is recruited into these foci, causing loss-of-function of the protein, which has been linked to critical DM1 features (5, 9) . An antagonistic splicing factor of MBNL1 activity, CUGBP Elav-like family member 1 (CELF1), is hyper-phosphorylated and subsequently stabilized in DM1 (10) . Despite its ability to bind to CUG triplets, CELF1 is not sequestered into CUG-RNA foci (11, 12) . Instead, CELF1-mediated alterations in DM1 models require the presence of DMPK (11, 13) . Together, MBNL1 and CELF1 regulate critical alternative splicing transitions during heart and skeletal muscle development, which are dysregulated in DM1 (14 -16) .
In addition to alternative splicing, several other mechanisms have been recently found, which add complexity to the molecular pathology of DM1. These include repeat-associated non-ATG translation (RAN) (17) , bidirectional transcription (18) , aberrant DNA methylation (19, 20) or microRNA (miRNA) dysregulation, among others (21, 22) . miRNAs are short non-coding RNAs present in all eukaryotes, which regulate gene expression by decreasing their target mRNA levels, or by blocking their translation (23, 24) . miRNA biogenesis is well understood. In the canonical biogenesis, miRNAs are produced from long primary transcripts (pri-miRNA) that are first processed by Drosha in the nucleus to generate one or more hairpin structures known as pre-miRNA. Then, Dicer orchestrates another cut to generate the mature miRNA in the cytoplasm (Supplementary Material, Fig. S1 ). Computational methods have predicted that miRNAs account for 1% of all eukaryotic genes, and that one-third of the transcriptome may be regulated by miRNAs (25) . In animals, miRNAs participate in virtually all cell functions, including the regulation of differentiation, proliferation and apoptosis. A subset of miRNAs known as myomiRs are highly enriched in heart and skeletal muscles, where they can regulate muscle function in development and disease (26 -28) . Eisenberg et al. (29) described an miRNA expression profile from 10 human muscle disorders and identified 185 miRNAs that were dysregulated in almost all cases, further demonstrating the importance of miRNAs in muscle function. In DM1, some studies using muscle biopsies have described that miR-206, miR-210, miR-1 and miR-335 are over-expressed in skeletal muscle, whereas miR-29b, miR-29c and miR-33 are downregulated. However, independent studies have found either no changes in miR-1 levels or a reduction of this miRNA, as well as an altered cellular distribution of muscle-specific miR-1, miR-133b and miR-206 (21, 22, 30) .
Given that the origin of miRNA alterations in DM1 remains uncertain, in this work we have used a Drosophila model expressing CTG repeats in the absence of an ATG start codon, in order to study the contribution of CTG expansions to miRNA defects. We have found that the expression of 20 miRNAs is affected by expression of CTG repeats in DM1 flies. Dysregulation of conserved miRNAs miR-1, miR-7 and miR-10a also occurred in DM1 patients, where a number of target transcripts were consistently up-regulated. For some of these miRNAs, reduced levels originated from down-regulation of their pri-miRNA precursors and/or Muscleblind loss-of-function. Importantly, over-expression of miR-10 in Drosophila extended the lifespan of model flies. All together, these results contribute to our understanding of the nature and pathological implications of miRNA dysregulation in DM1.
RESULTS

Expression of expanded CTG repeats in Drosophila causes reduction of defined miRNAs
An increasing number of miRNAs have been found altered in DM1 patients, where CTG repeats are present in the context of full-length DMPK transcripts. In order to identify miRNA alterations directly caused by CTG expansions, we targeted the expression of 480 interrupted CTG repeats, UAS-(iCTG)480, to the Drosophila muscles with the Myosin heavy chain (Mhc)-Gal4 driver line. We obtained the miRNA transcriptome (miRNome) profile of two independent i(CTG)480 transgenic lines (Mhc-Gal4.UAS-i(CTG)480 1.1 and Mhc-Gal4.UAS-i(CTG)480 2.2), using SOLiD TM 3 sequencing of small-RNA libraries. Small-RNA libraries from Mhc-gal4/+ flies were used as controls. Statistical analysis revealed 20 miRNAs differentially expressed in DM1 flies versus control individuals ( Fig. 1A and Supplementary Material, Table S1 ). Nineteen of these were down-regulated in the presence of CTG expansions, whereas one was up-regulated.
Among the 20 miRNAs altered in DM1 flies, we chose to validate the effect of CTG repeats on miR-1, miR-7 (given their conservation in humans) and on miR-1003 (given its miRtronic nature) by northern blot of small RNAs, using LNA probes and normalizing against the endogenous small nuclear RNA (snRNA) U6. Consistent with our SOLiD TM 3 sequencing data, northern blot analysis revealed expression values for miR-1, miR-7 and miR-1003 that were reduced by 30% (P ¼ 0.0047), 50% (P ¼ 0.0052) and 30% (P ¼ 0.0384), respectively, compared with control flies (Fig. 1B  and C) . Therefore, these results demonstrate that expanded CTG-repeat expression affects the Drosophila miRNome mainly by causing a reduction in the level of specific miRNAs.
CTG-induced down-regulation of miR-1, miR-7 and miR-10 is conserved between Drosophila and DM1 patients Among the 20 miRNAs that we found altered in CTG-expressing flies, miR-1, miR-7 and miR-10 were conserved between Drosophila and humans (Supplementary Material, Fig. S2 ). In order to validate the relevance of our findings in DM1, we used qRT -PCR to study the levels of human miR-1, miR-7, and miR-10 (miR-10a and miR-10b) in Human Molecular Genetics, 2013, Vol. 22, No. 4 705 skeletal muscle biopsies (biceps, vastus and deltoid) from five DM1 patients (aged 47 + 5) compared with biopsies from three healthy individuals (aged 58 + 11) and normalized against endogenous snoRNA U48. Statistical analysis revealed a significant reduction in the levels of miR-1 (72%; P ¼ 0.0022), miR-7 (80%; P ¼ 0.0004) and miR-10a (60%; 0.0271) in DM1 patients compared with control individuals ( Fig. 2A) . miR-10b, which is less similar to Drosophila miR-10 than human miR-10a, showed a non-significant increase. Therefore, these results demonstrate the conservation of miRNA dysregulation triggered by expanded CTG repeats between our i(CTG)480 Drosophila model and humans. Interestingly, miR-1 levels had been previously studied in DM1 patients by independent groups, which found either no changes in miR-1 levels (22), a 2.1-fold reduction (21), or a 1.9-fold up-regulation (30); whereas miR-7 and miR-10 had not been tested, nor associated with the disease before.
To investigate whether miR-1, miR-7 and miR-10a dysregulation had an effect on their mRNA targets, we used gene microarray data from muscle biopsies of DM1 patients previously generated in our laboratory, where a number of misexpressed genes had been identified (unpublished data). Of all Targetscan (25) predictions that were represented among these genes, we found 21 miR-1 targets, 14 miR-7 targets and 7 miR-10 targets. All of them but one were significantly up-regulated (.10-fold) in DM1 muscle biopsies (Supplementary Material, Table S2 and Fig. 2B ; upper graphs). However, the target transcripts of three randomly selected control miRNAs (let7a, miR-340 and miR-454) showed changes in their expression levels that indistinctly included up-and down-regulation, ruling out an miRNA-mediated effect, and further supporting the specificity of our results ( Fig. 2B; lower graphs) . Among the total of up-regulated targets of miR-1, miR-7 and miR-10, a subset of 13 were chosen for their validation by qRT -PCR from muscle biopsies of six DM1 patients. An apparent up-regulation of mRNA levels was observed in each case, although only seven of these changes were statistically significant ( Fig. 2C -E ; Supplementary Material, Table S3 ). Confirmed genes encoded proteins that participated in a mixed range of cellular processes, including antioxidant enzyme SOD1, transcriptional regulator SMARCA4 and nucleotide exchange factor NET1 (miR-1; machinery UBE21 (miR-10; Fig. 2E ). Thus, our results suggest a wide pathologic potential of miRNA dysregulation in DM1. Finally, to assess whether miR-1, miR-7 and miR-10 alterations originated during muscle differentiation, we also studied the levels of miR-1, miR-7, miR-10a and miR-10b in control and DM1-derived human skin fibroblasts before and after they had been induced to turn on the myogenic program by expression of the murine MyoD (31). Before myogenesis was induced, the levels of miR-1 or miR-10b did not differ between control and DM1 fibroblasts (P ¼ 0.6534 and P ¼ 0.8049, respectively); whereas miR-10a was slightly increased (P ¼ 0.0048), and miR-7 was notably reduced in DM1 fibroblasts compared with controls (P ¼ 0.0009) ( Fig. 3A ; Supplementary Material, Table S4 ). After the induction of myogenesis, however, all four miRNAs were significantly reduced in DM1 cells (miR-1, P ¼ 0.0248; miR-7, P ¼ 0.0312; miR-10a, P ¼ 0.0002; and miR-10b, P ¼ 0.0166). Interestingly, for miR-7, this reduction was less marked in muscle cells than in fibroblasts ( Fig. 3B and Supplementary Material, Table S4 ). These results suggest that different miRNA alterations in DM1 muscle cells may originate from different mechanisms.
Expanded CTG repeats alter the levels of defined pri-miRNA precursors SOLID TM 3 sequencing identified Drosophila miR-310, miR-311 and miR-312 among the initial 19 miRNAs that were reduced in CTG-expressing flies. Interestingly, these miRNAs formed an miRNA cluster (i.e. a group of miRNAs contained within the same gene) (32) denominated cluster miR-310 -313, which is transcribed as a polycistronic primary precursor. miR-313, which completes the cluster, showed a similar trend, although its reduction was not statistically significant ( Fig. 4A and Supplementary Material, Table S5 ). miR-960, miR-962 and miR-964, which were also altered in DM1 flies, were part of a second miRNA cluster (cluster miR-959 -964) located in the antisense (2) strand of the CG31646 gene. miR-959, miR-961 and miR-963, the rest of the members of this cluster, also showed a mild reduction in CTG-expressing flies ( −DDCt method, and their confidence intervals. sno-RNA RNU48 was used as the endogenous control. (B) Scattered plot representation of the microarray signal values of the altered transcripts predicted to be regulated by miR-1, miR-7 and miR-10a (Targetscan; upper row). Altered transcript targets of a subset of three randomly chosen miRNAs (let7a, miR-340 and miR-454) are also shown (lower row). Consistent with a decrease in miR-1, miR-7 and miR-10a, an up-regulation of their predicted targets was observed, whereas both up-and down-regulations were detected for let7a, miR-340 and miR-454 (Fisher's exact test, a ¼ 0.05). (C-E) qRT-PCR validation analysis from adult skeletal muscle biopsies of six DM1 patients and six healthy (control) biopsies. The expression levels of 13 selected miR-1 (C), miR-7 (D) and miR-10a (E) targets are shown relative to the control individuals. An up-regulation trend was observed in all cases, although only the indicated seven were statistically significant. In this case, GADPH was used as the endogenous control. Graph bars represent average fold changes of gene expression, calculated by the 2 −DDCt method, and their standard errors. * P , 0.05, * * P , 0.01 and * * * P , 0.001.
Human Molecular Genetics, 2013, Vol. 22, No. 4 707 Table S5 ). Therefore, these results suggested that the changes in the expression levels of these miRNAs could originate from a reduction in their pri-miRNAs. To confirm this hypothesis, we measured the pri-miRNA levels of both clusters by qRT -PCR from Mhc-Gal4.UAS-i(CTG)480 and Mhc-gal4/+ (control) flies ( Fig. 4D and E). Mhc-Gal4.-UAS-i(CTG)480 flies showed a significant reduction in the pri-miRNA levels of miR-310 -313 (P ¼ 0.0077) and miR-959 -964 (P ¼ 0.0368) clusters when compared with controls, demonstrating a CTG-mediated effect on both transcription units. We also measured the levels of sense (+) strand mRNA from the CG31646 gene and found no significant changes compared with controls (P ¼ 0.5330), ruling out a non-specific effect on miR-959-964 caused by a reduction of the expression of this gene (Fig. 4E ). The pri-miRNA levels of the cluster miR-2a-1-2b-2, which encodes miRNAs that were not modified by CTG expression in our SOLiD TM 3 analysis, were also studied. No significant differences in the pri-miRNA of this cluster were detected in CTG-expressing flies when compared with controls ( Fig. 4C and F; P ¼ 0.2368), further confirming the specificity of the effect of CTG repeats on pri-miRNA production of defined miRNAs. Molecular mapping of the i(CTG)480 1.1 and 2.2 insertions used in this study showed no proximity to the miR-310 -313 or miR-959 -964 clusters, excluding the possibility of a transcriptional repression caused by CTG-induced alterations of the local chromatin structure (Supplementary Material, Table S6 ).
Based on these findings, we next investigated whether the pri-miRNA levels of conserved miRNAs miR-1, miR-7 and miR-10 could also be affected by expression of expanded CTG repeats. In Drosophila, qRT -PCR analysis revealed that the pri-miRNAs of miR-1 and miR-10 were comparable with control flies (P ¼ 0.3435 and 0.7095, respectively). However, the pri-miRNA of miR-7 was significantly reduced ( Fig. 4G ; P ¼ 0.0420). This effect was also observed in skeletal muscle biopsies from six DM1 patients, where the primiRNA levels from human miR-7 genes pri-miR-7-1 and pri-miR-7-2, but not pri-miR-7-3, were significantly reduced compared with healthy controls (P ¼ 0.0339, P ¼ 0.0209 and P ¼ 0.0917, respectively, Fig. 4H ). Therefore, these results demonstrate that, at least partly, miR-7 is reduced in Drosophila and in DM1 patients due to a down-regulation of its pri-miRNA precursor.
Muscleblind is necessary for the regulation of miR-1 and miR-7 in Drosophila
In addition to the down-regulation of specific primary precursors, changes in miRNA levels may also occur at a downstream level, including the regulation of their biogenesis or their stability. Human MBNL1 has been described to participate in the biogenesis of miR-1 (21) by binding to a UGC motif located within its pre-miRNA, favoring the generation of mature miR-1. To confirm whether the Drosophila homolog of MBNL1 (Mbl) was also involved in the differential expression of miR-1 in Drosophila, we used transgenic flies carrying an RNAi construct targeted against all Mbl isoforms (UAS-IR-mbl). In a wild-type background, mbl silencing using an Mhc-Gal4 driver line (Mhc-Gal4.UAS-IR-mbl) caused a significant reduction of miR-1 levels as detected by northern blot (P ¼ 0.0102). On the contrary, over-expression of MblC isoform did not induce changes in miR-1 ( Fig. 5A and B; Supplementary Material, Fig 3A) . This indicates that (i) other Mbl isoforms may also be important in regulating the levels of miR-1, or (ii) that the amount of miRNA qRT-PCR amplification of mature miR-1, miR-7, miR-10a and miR-10b miRNAs from healthy and DM1 patient-derived fibroblasts (having 333 CTGs at the time of diagnosis, in 2010). miRNA levels were measured before and after cell induction to activate myogenic transdifferentiation (MT). miR-7 was reduced in both DM1 fibroblasts and DM1 transdifferentiated myoblasts (B), whereas miR-1 (A), miR-10a (C) and miR-10b (D) were down-regulated only after the myogenic program had been activated in DM1 cells. snoRNA U48 was used as the endogenous gene, and all data were normalized relative to the control group. Two biological samples and three technical replicates per biological sample were used. All graph bars represent average fold changes of miRNA expression, calculated by the 2 −DDCt method, and their standard errors. * P , 0.05, * * P , 0.01, * * * P , 0.001. Additional statistical data are shown in Supplementary Material, Table S4 .
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precursor available might be the limiting factor during biogenesis, with endogenous Mbl levels being sufficient to saturate the process. Supporting the second hypothesis, mblC overexpression significantly rescued miR-1 levels in DM1 flies, where endogenous Mbl function is compromised ( Fig. 5A and B; P ¼ 0.0435). mbl silencing in a wild-type background also reduced miR-7 levels, although this change was not statistically significant (P ¼ 0.1978). However, in this case, mblC over-expression did not affect this miRNA even in the presence of CTG repeats ( Fig. 5C and D and Supplementary Material, Fig. S3B ; P ¼ 0.7751). Therefore, the relative contribution of Mbl to the generation of miR-1 and miR-7 seems to be different; and additional factors that are independent of Mbl would participate in the regulation of miR-7. Interestingly, two of the miRNAs that we found downregulated in Drosophila, miR-1003 and miR-1006, were miRtrons (i.e. miRNAs that arise from spliced-out introns). Given that splicing alterations are a hallmark of DM1, we also analyzed the splicing of the introns that host miR-1003 and miR-1006 (intron 6 of the CG6695 gene, and intron 4 of the VhaSFD gene, respectively). Analysis of miR-1004, an miRtron not found altered in CTG-expressing flies, was also 2) compared with controls (Mhc-Gal4/+). No differences between groups were detected for the miRNA cluster miR-2a-1-2b-2, which was used as a negative control (C). (D-F) qRT-PCR amplification of the pri-miRNAs from clusters miR-310-313, miR-959-964 and miR-2a-1 -2b-2 from adult flies confirmed a CTG-dependent reduction in the expression levels of the pri-miRNAs of clusters miR-310-313 (D) and miR-959-964 (E), but not miR-2a-1-2b-2 (F), when compared with controls. The strand of the CG31646 gene opposite to the strand that contains the cluster miR-959-964 was used as an additional control, for which no expression differences were observed (E). (G) The pri-miRNAs of conserved miRNAs miR-1, miR-7 and miR-10 were also measured in Drosophila by qRT-PCR. Only the pri-miRNA of miR-7 was significantly reduced in CTG-expressing flies. In (D-G), four biological replicates (n ¼ 50 per replicate), and three technical replicates per biological sample, were used. Biological samples included two female groups and two male groups, and normalization was carried out relative to the corresponding gender controls. tubulin84B was used as the endogenous gene. (H) In human skeletal muscle biopsies, qRT-PCR revealed that the pri-miRNAs from two of the three genes encoding human miR-7 were down-regulated in DM1 patients (n ¼ 6 individuals; three technical replicates per individual) compared with healthy individuals (n ¼ 6 individuals; three technical replicates per individual). In this case, GADPH was used as the endogenous gene. All graph bars represent average fold changes of gene expression, calculated by the 2 −DDCt method, and their standard errors. * P , 0.05, * * P , 0.01.
included as a control. As expected, the splicing of intron 19 of the CG43707 gene (miR-1004 precursor) was unaffected (Supplementary Material, Fig. S4A and B) . We did not detect VhaSFD transcripts containing intron 4 (miR-1006 precursor), either in control or in DM1 flies (Supplementary Material, Fig. S4A ), suggesting that this intron is completely spliced out in both cases. However, the levels of CG6695 transcripts containing intron 6 (miR-1003 precursor) were reduced by 24% in CTG-expressing flies compared with controls (P ¼ 0.0080; Supplementary Material, Fig. S4A and B) , indicating that intron 6 is spliced out at higher levels in DM1 flies than in controls. Taken together, the reduced levels of mature miR-1003 and miR-1006 in CTG-expressing flies cannot be explained by reduced splicing of their host transcripts, and would instead occur at a more downstream level.
Over-expression of miR-10, but not miR-1 or miR-7, increases lifespan in CTG-expressing flies
To date, the pathogenicity of miRNA alterations in DM1 remains unclear. We studied the physiological relevance of CTG-induced miRNA down-regulation by performing a series of phenotypic rescue experiments using our DM1 Drosophila model, where we over-expressed miR-1, miR-7 or miR-10 under the control of the Mhc-Gal4 driver line. We previously described that flies expressing i(CTG)480 in the musculature had a reduced lifespan compared with control individuals (2). Here, Mhc-Gal4 UAS-i(CTG)480.UAS-GFP flies showed a median survival (MS) of 15 days at 258C, whereas control flies (Mhc-Gal4.UAS-GFP) showed an MS of 33 days at the same temperature ( Fig. 6 ; P , 0.0001).
Flies co-expressing i(CTG)480 and miR-1 (Mhc-Gal4
UAS-i(CTG)480.UAS-miR-1) showed an intriguingly reduced MS (10 days; P , 0.0001) compared with CTG-expressing flies ( Fig. 6A and D) . This effect was not due to the toxicity of miR-1, as flies over-expressing miR-1 alone (Mhc-Gal4.UAS-miR-1) showed a lifespan comparable with Mhc-Gal4.UAS-GFP controls (Fig. 6A) . The survival curves of flies co-expressing i(CTG)480 and miR-7 (Mhc-Gal4 UAS-i(CTG)480.UAS-miR-7) also showed a mild but significant reduction in lifespan (MS of 11.5 days) compared with their controls, which co-expressed i(CTG)480 and dsRED (Mhc-Gal4 UAS-i(CTG)480.-UAS-dsRED; MS of 13 days) ( Fig. 6B and D ; P ¼ 0.0109). In this case, this effect could be explained by the toxicity of miR-7, as over-expression of miR-7 alone (Mhc-Gal4.-UAS-miR-7) resulted in an MS of 27 days, significantly lower than that of individuals expressing dsRED (Mhc-Gal4.UAS-dsRED; MS of 29.5 days; P ¼ 0.0310) (Fig. 6B) .
Finally, co-expression of i(CTG)480 with miR-10 (Mhc-Gal4 UAS-i(CTG)480.UAS-miR-10) significantly increased lifespan compared with controls that co-expressed i(CTG)480 and GFP, resulting in an MS of 18 days ( Fig. 6C and D ; P , 0.0001). In addition, over-expression of miR-10 alone (Mhc-Gal4.UAS-miR-10) did not affect the lifespan of flies (MS of 35 days; Fig. 6C ).
Taken together, although further studies are required to fully understand the implications of miR-1, miR-7 and miR-10 dysregulation in CTG-mediated toxicity, our results demonstrate that miR-10 down-regulation triggered by CTG expansions has a negative, but partially reversible, physiological impact, supporting the pathologic role and therapeutic potential of this miRNA in DM1.
DISCUSSION
Dysregulation of specific miRNAs in DM1 patients had been previously described (21, 22, 30) . Here, we have studied the contribution of CTG expansions to miRNA defects in DM1, by analyzing changes in the muscle miRNome of a Drosophila model of CTG toxicity (2). Using SOLiD TM 3 sequencing, we have identified 20 miRNA alterations caused by expression of CTG repeats. Of these, 19 were specifically down-regulated in our Drosophila model, whereas only 1 was up-regulated. Therefore, the alterations on miRNA regulation caused by CTG expression seem to trigger a reduction, rather than an increase, of miRNA expression levels. This effect was also observed in DM1 patients for all altered miRNAs that were conserved between Drosophila and humans: miR-1, an miRNA previously associated with DM1 (21,30); and miR-7 and miR-10a, for which no previous link had been described.
Importantly, the conservation of miR-1, miR-7 and miR-10 defects between our fly model and DM1 patients confirms that: (i) the miRNA down-regulation found in Drosophila is specific, and not the consequence of a reduced contribution of the muscle transcriptome to the total transcriptome; and (ii) the dysregulation of these three miRNAs occurs in the presence of CUG-repeat transcripts devoid of additional DMPK sequences. Although it is possible that other coding or non-coding regions within the DMPK gene contribute to miRNA defects in DM1, this is the first demonstration that CTG expansions are directly linked to alterations in miRNA regulation. Of note, the fly model used in this work contains 480 CTG repeats interrupted every 20 units by the CTCGA sequence: i(CTG)480. The i(CUG)480 RNA is predicted to form a double-stranded structure that closely resembles the hairpin formed by 480 pure repeats, both of them having similar folding energies (Supplementary Material, Table S7 ). The existence of complex repeat interruptions at the DM1 locus has been reported to attenuate the severity of symptoms in patients (31) (32) (33) . Although the CTCGA interruption in the i(CTG)480 transgene does not resemble any of these variant repeat alleles, it is possible that its presence might also modify CTG-induced phenotypes in our flies. For example, the CUCGA interruption would determine the length of any putative repeat-associated non-ATG (RAN) translation products, should these be generated in Drosophila, as i(CAG)480 transcripts would produce polyS, polyA and polyQ peptides in consecutive tracts of 20 amino acids linked by 1 -2 amino acids. Note that RAN translation from pure CAG repeats produces individual polyS, polyA and polyQ peptides [Supplementary Material, Table S7 and (17,34)]. Bearing all this in mind, the conservation of miR-1, miR-7 and miR-10 defects between our fly model and DM1 patients represents important evidence that dysregulation of at least these three miRNAs occurs independently of the CUCGA repeat interruption in the UAS-i(CTG)480 transgene. By studying the expression levels of the predicted target genes of miR-1, miR-7 and miR-10 in skeletal muscles from DM1 patients, we identified a total of 42 targets that were dysregulated, 41 of them being up-regulated and only 1 downregulated. The up-regulation of these targets is consistent with a reduced degradation by their respective miRNA regulators. qRT -PCR analysis confirmed this general trend, and validated at least seven of these alterations in DM1 patients, which had not been previously described to be triggered by miRNA dysregulation. Affected genes did not fall into related functional categories, but instead involved multiple cellular processes. Moreover, miR-1, miR-7 and miR-10 downregulation could have an even higher impact on gene expression, if we take into consideration that these miRNAs might also affect the translation of additional gene targets, without affecting the levels of their messenger transcripts. Therefore, our results highlight the wide number of cellular mechanisms potentially affected by CTG-mediated disruption of miRNA regulation.
A number of miRNAs found altered in DM1 to date are encoded in introns, thus suggesting a link between pre-mRNA splicing and miRNA processing. Given that splicing alterations are a hallmark of DM1, both defects could have a common origin. In our study, two Drosophila miRNAs affected by CTG expression, miR-1003 and miR-1006, are miRtrons. The precursor intron of miR-1006 was completely spliced out both in control and in DM1 flies, suggesting that miR-1006-reduced levels in CTG-expressing flies do not originate from defects in the splicing regulation of its host transcript, but would instead occur at a more downstream level. For miR-1003, we found that its precursor intron is spliced out at higher levels in DM1 flies than in control individuals. However, mature miR-1003 levels are reduced in DM1 flies. Increased levels of spliced-out miR-1003 precursor could arise from a response mechanism triggered by the cells to compensate for the reduced levels of mature miR-1003, whereas the mature miRNA reduction itself would occur at a downstream level. In this study, we have also found altered miRNAs that belong to the same cluster (i.e. singletranscription units containing several miRNAs regulated by an upstream promoter) (35) . In Drosophila, the pri-miRNA levels of clusters miR-310 -313 and miR-959 -964 were reduced in CTG-expressing flies compared with controls. Additionally, the levels of pri-miRNA for miR-7, but not for miR-1 or miR-10, were down-regulated in CTG-expressing flies and in skeletal muscle of DM1 patients. Therefore, our results demonstrate that pri-miRNA transcription/stability is involved in at least part of the miRNA defects described in this work, supporting the idea of different origins for miRNA dysregulation in DM1.
In our DM1 model flies, the CTG-mediated reduction of miR-1 seemed to be dependent on Mbl, as over-expression of MblC in CTG-expressing flies rescued miR-1 levels. Moreover, mbl silencing in a wild-type background caused a strong reduction of miR-1. These results are consistent with previous reports that described a direct implication of MBNL1 in the biogenesis of human miR-1 (21) . In that study, the authors reported that MBNL1 binds to a UGC motif located within the loop of the pre-miRNA, facilitating the Dicer processing that generates the mature miR-1. According to this model, MBNL1 sequestration by CUG repeats would lead to a reduction of miR-1 levels in DM1, which the authors validated in cardiac muscle from DM1 patients (2.1-fold reduction) (21) , and is consistent with our results in flies and DM1 muscle biopsies. However, other reports have described a different situation for miR-1. When Perbellini et al. (30) measured miR-1 from biceps muscles of DM1 patients, a 1.9-fold up-regulation of this miRNA, together with an increase in eight of its predicted targets, was found. This difference may be explained by the different types of muscles analyzed and/or their use of controls with suspected neuromuscular disorders. Intriguingly, another recent study reported no changes in miR-1 levels in the vastus lateralis muscle of DM1 patients (22) . It is, therefore, possible that miR-1 dysregulation is particularly sensitive to cellular contexts, which could include factors such as the number of CTG repeats or the age of the patients.
In our experiments, mbl silencing also reduced miR-7 levels. However, this reduction was weaker than that observed for miR-1. Moreover, over-expression of MblC did not rescue the effect of CTG expansions on miR-7 levels. In our transdifferentiation cell model, miR-7 levels were reduced both before and after myogenesis, whereas miR-1 and miR-10 were only significantly affected after differentiation. In addition, primiRNA down-regulation occurred for miR-7, but not for miR-1 or miR-10. These observations further suggest that miR-7 alterations in DM1 occur via a different mechanism, although further studies will be required to clarify the specific factors involved in each case.
The different behavior of miR-1, miR-7 and miR-10 in the presence of CTG expansions might translate into different consequences to the homeostasis of the cells. The pathological relevance of miRNA dysregulation in DM1 is unclear, as alterations previously described in miRNA levels could correspond either to a response mechanism or to a pathogenic consequence. Here we have shown that partial restoration of miR-10 levels by over-expression of this miRNA in the Drosophila muscles partially rescued the reduced lifespan phenotype of DM1 flies. This demonstrates that miR-10 down-regulation contributes to CTG-mediated toxicity. On the other hand, not all miRNA alterations triggered by CTG expression seemed to have a phenotypic impact, as overexpression of miR-1 or miR-7 did not rescue the CTG-induced phenotype, and even reduced the survival of flies. For miR-7, this effect could originate from additive toxicity, as miR-7 over-expression alone affected the lifespan of flies. However, the case of miR-1 is more intriguing, since this miRNA was not toxic per se. Given that human MBNL1 has been described to bind to miR-1 directly, it would be possible that the CTG-specific detrimental effect observed for miR-1 over-expression resulted from a sequestration of Drosophila Mbl by excess of miR-1.
In summary, this study sheds light onto our understanding of the molecular mechanisms behind gene expression dysregulation in DM1 and CTG toxicity, providing a direct link between miRNA dysregulation and RNA toxicity in DM1, identifying a number of mechanisms and predicted target genes that are affected by CTG expansions and supporting the pathogenic potential of at least part of them. Table S7 ). UAS-MblC flies were described in Garcia-Casado et al. (36) . UAS-IR-mbl flies will be described elsewhere (37) . UAS-miR-1 flies were a gift from Dr Sokol (Dartmouth Medical School, USA) (38) . UAS-miR-7 flies were a gift from Prof. Cohen (Institute of Molecular and Cell Biology, Singapore, Singapore) (39) . UAS-miR-10 flies were a gift from Dr Gehrke (Stanford University School of Medicine, USA) (40) . Flies used for SOLiD TM 3 sequencing were fed with commercial instant Drosophila food (Carolina Biological Supply Company) in order to avoid variations in home-made food. All crosses were carried out at 258C.
Small RNA library generation and next-generation sequencing
Two biological replicates per genotype were used (control: Mhc-Gal4/+; DM1: Mhc-Gal4.UAS-i(CTG)480), each of which containing 50 Drosophila males of the same age (2-day-old flies; state of muscle degeneration 45%). Two different DM1 lines were used (UAS-i(CTG)480 1.1 and UAS-i(CTG)480 2.2) to rule out any transgene-specific effect (Supplementary Material, Table S1 ). Total RNA was extracted from each group and the small RNA fraction was enriched using the miRVana kit (Ambion). Small RNA was run in 15% acrylamide:bisacrylamide 19:1 gels and the 15-30 nt fraction was sliced out and eluted with 1 M NaCl overnight at 48C. Purification was carried out using the MEGAclear Kit (Ambion). The quality of purified small RNAs (50 ng) was analyzed by capillary electrophoresis (Agilent 2100 Bioanalyzer). Libraries for SOLiD TM 3 sequencing were prepared following the manufacturer's protocol (Small RNA Expression Kit, Applied Biosystems), and two technical replicates were conducted for UAS-i(CTG)480 1.1 and UAS-i(CTG)480 2.2 as a control of reproducibility (Supplementary Material, Table S1 ). Briefly, small RNA samples (15 ng) were hybridized and ligated overnight with the adapter mix, reversetranscribed and PCR-amplified (15 cycles). The primers used in this PCR included a unique six-nucleotide barcode for each sample. A single emulsion PCR reaction was used to couple the barcoded libraries to P1-coated beads as per the standard Applied Biosystems protocol. After emulsion PCR, template beads were enriched in a glycerol gradient and deposited onto the surface of glass slides for SOLiD sequencing. Sequencing was performed using 35 bp chemistry on a version 3.0 SOLiD machine (SOLiD TM 3) . Approximately 200 million of 35 nt reads were produced for all barcoded samples.
Bioinformatic analysis
From the SOLiD TM 3 sequencing data, low-quality reads were first removed from the data set (at least QV ≥ 10 in the first 10 bases). Filtered reads were then mapped against the Drosophila melanogaster genome (version r5.23), using the software Small_RNA_Tool_v0.5.0 (http://solidsoftwaretools.com/gf/) and allowing up to two mismatches in the first 18 nt and up to three mismatches in the entire read. A custom pipeline was then used to select reads that mapped uniquely to a point of the Drosophila genome, which represented the usable sequence data. mirBase (version 13.0) and custom scripts were applied in order to identify known miRNAs. Contaminations by protein-coding genes or other ncRNAs (rRNAs, tRNAS, snoRNAs, etc.) were discarded from the final data set. miRNA counts were normalized per million of reads that mapped uniquely, in order to yield the relative transcript abundance in the original sample. Normalized miRNA counts were used to analyze significant changes in expression profiles between Mhc-Gal4.i(CTG)480 and Mhc-Gal4/+ flies, using the dCHIP Analysis Software. Non-agglomerative hierarchical clustering was carried out using UPGMA (unweighted pair group method with arithmetic mean) analysis as previously reported (41) . Statistically significant down-and up-regulated miRNAs were obtained using an ANOVA test with false discovery rate (FDR) correction (a ¼ 0.05).
Northern blot
For each biological replicate, total RNA from 50 adult male flies was extracted using Tri-Reagent (Sigma). The quality of the RNA was analyzed by capillary electrophoresis. Ten micrograms of total RNA was fractionated on a denaturing 15% polyacrylamide gel (7 M urea), electrotransferred to a Hybond-N + membrane (Roche) and fixed by ultraviolet crosslinking (1200 mJ). Membranes were probed with DIG-labeled LNA probes (EXIQON) complementary to the mature miRNAs or with 5 ′ -DIG-labeled DNA probes (snoRNA U6, loading control) (Supplementary Material, Table S8 ) at 528C overnight in hybridization buffer (36 mM Na 2 HPO 4 , 14 mM NaH 2 PO 4 , 1 mM EDTA and 7% SDS, pH 7.2). Anti-DIG-AP Fab fragment (Roche) was incubated at 1:10 000 for 1 h at room temperature. CDP-Star chemiluminescent substrate for AP (Roche) was used for detection. Images were taken in an ImageQuant LAS4000 (GE Healthcare). Quantification of band intensity was carried out using the ImageJ software. Pairs of samples were compared using a two-tailed t-test (a ¼ 0.05), applying Welch's correction when necessary.
qRT -PCR from flies
For each biological replicate, total RNA from 50 adult flies was extracted using Trizol (Sigma). One microgram of RNA was digested with DNaseI (Invitrogen) and retrotranscribed with SuperScriptII (Invitrogen), using random hexanucleotides. For each biological replicate, qRT -PCR reactions from 10 ng of cDNA were carried out per triplicate using SYBR Green PCR Master Mix (Applied Biosystems; Supplementary Material, Table S8 ). tubulin84B was used as the 
Drosophila lifespan analysis
A total of 100-150 newly hatched flies per genotype were collected, placed in tubes containing standard nutritive medium and kept at 258C. The number of deceases was scored on a daily basis, and flies were transferred into fresh medium every 3 -4 days. Survival curves were obtained using the Kaplan -Meier method, and statistical curve comparisons were carried out according to the log-rank (Mantel -Cox) test (a ¼ 0.05).
DM1 patients and skeletal muscle biopsies
All biopsy specimens were taken after informed consent was obtained. Muscle biopsies used for qRT -PCR studies were collected at the University Hospital Donostia (San Sebastian, Spain) and at the University Hospital La Fe (Valencia, Spain), using institutionally approved protocols by an ethical board. A detailed description on muscle type, sex, age and number of repeats is provided in Supplementary Material, Table S9 . For the determination of the CTG repeat size, genomic DNA isolated from peripheral blood leukocytes (42) and Southern blots probed with 32-P-labeled cDNA25 or PCR amplification of CTG-repeat regions (DM101 and DM102 primers) (43 -45) were performed. Muscle biopsies used for the analysis of HUMAN EXON 1.0 ST arrays and subsequent qRT -PCR validation of mRNA targets will be published elsewhere.
qRT -PCR from human samples
Human muscle biopsies were homogenized in a Tissuelyser II (Qiagen), using QIAzol (Qiagen). RNA was then purified with a QIAcube (Qiagen), and the small RNA fraction was enriched using the miRNeasy Mini Kit (Qiagen). For mature miRNA analysis, 40 ng of RNA from five DM1 patients and three controls were used as a template for cDNA synthesis with TaqMan microRNAs RT (Applied Biosystems), following the manufacturer's recommendations. Twelve nanograms of the cDNA template was then amplified per triplicate by qRT -PCR, using specific stem -loop RT-type primers and TaqMan miRNA probes (Applied Biosystems; Supplementary Material, Table S8 ). qRT -PCRs assays were carried out in a 7900 HT Fast Thermal Cycler (Applied Biosystems) using the SDS software (version 2.2.2.). sno-RNA RNU48 was used as the endogenous control. For the analysis of human pri-miRNA and mRNA target levels, 1 mg of RNA from six DM1 patients and six healthy controls was used as a template for cDNA synthesis (RETROscriptw Kit; Applied Biosystems). An amount of 20 ng of the cDNA template was then amplified per triplicate by qRT -PCR using SYBR Green PCR Master Mix (Applied Biosystems; Supplementary Material, Table S8 ). In this case, GADPH was used as the endogenous control. In all cases, relative expression to the endogenous gene and the control group was obtained by the 2 −DDC t method. Pairs of samples were compared using a twotailed t-test (a ¼ 0.05), applying Welch's correction when necessary.
Cell culture and qRT -PCR from transdifferentiated cells
Human fibroblasts were isolated from skin biopsies of a DM1 patient with 333 CTG repeats at the time of diagnosis (2010) and healthy individuals (Supplementary Material, Materials and Methods), after informed consent was obtained, according to the guidelines of the Committee on the Use of Human Subjects in Research of the Donostia Hospital (San Sebastian, Spain). Fibroblasts were cultivated in DMEM (Invitrogen), 10% FBS (Invitrogen) and antibiotics, in humidified incubators at 378C in 5% CO 2 . Transdifferentiation into myoblastlike cells was induced by turning on the myogenic program, using retroviral-mediated expression of murine MyoD under the control of the Tet-on inducible construct (42) . Transduction experiments using lentiviral vectors were performed overnight in the presence of polybrene (4 mg/ml; Sigma-Aldrich), and transduction efficiency was confirmed by MyoD imunostaining 1 day after inducing differentiation. More than 80% of the cells expressed MyoD, using a multiplicity of infection (MOI) of 20 without vector-associated cytotoxicity (not shown). The lentiviral vector titer was determined by qRT -PCR. To induce differentiation, cells in confluence were transferred to DMEM supplemented with 2% horse serum, 1% penicillin/streptomycin, transferrin (100 mg/ml) and insulin (10 mg/ml; Sigma-Aldrich, St Louis, MO, USA), and doxycyclin (2 mg/ml; Sigma-Aldrich) was added in the differentiation medium. Before (day 0) and after (day 10) transdifferentiation was induced, cells were collected, and RNA extracted with the miRNeasy Mini Kit (Qiagen). qRT -PCR was performed using specific stem -loop RT-type primers and TaqMan miRNA probes as described above and in Supplementary Material, Table S8 . Relative expression to the endogenous gene and to the control group was obtained by the 2 −DDC t method. Pairs of samples were compared using a two-tailed t-test (a ¼ 0.05), applying Welch's correction when necessary.
